Neuromodulation from Theory to Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: closed (28 February 2023) | Viewed by 27949
Special Issue Editors
2. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
Interests: neuromodulation; pain perception modulation; neurophysiology; neuroplasticity
Special Issues, Collections and Topics in MDPI journals
Interests: neuromodulation; pain perception modulation; neurophysiology; neuroplasticity
Special Issues, Collections and Topics in MDPI journals
2. Centre du Cerveau, University Hospital of Liège, Liège, Belgium
Interests: brain injury; disorders of consciousness; neuromodulation; rehabilitation; neurophysiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent evidence reveals how the nervous system is involved in almost all physiological activities of the human body, from cardiorespiratory rhythm and inflammation to perception and consciousness. Consequently, the nervous system's role is fundamental to keeping the “health–disease” balance, resilience across life, and overall well-being. Neuromodulation includes a myriad of non-pharmacological therapeutic approaches that aim to modulate nervous system activity to restore maladaptive neuroplasticity associated with multiple conditions, such as chronic pain, neurodegenerative diseases, brain injury, mental health conditions, and inflammatory diseases. The main intervention types include transcranial electrical stimulation (tES), transcranial magnetic stimulation (TMS), spinal cord stimulation, nerve stimulation, and behavioral therapies such as meditation, mindfulness, mental imagery, and hypnosis. These techniques have shown positive effects on several medical conditions; however, their clinical validation, regulatory approval, and systematic use are still incipient, mainly due to unpowered studies, inappropriate parameter selection, and lack of evidence integration. To accelerate the knowledge translation of neuromodulation, we must build a bridge between theoretical/technological development, clinical trial findings, meta-synthesis methods, and implementation strategies, including cost-effectiveness studies. A coherent and organized integration among these disciplines will foster neuromodulation translation to the clinic and unlock these therapies' real potential.
This Special Issue aims to create a space for “cross-talk” between disciplines about the clinical translation of neuromodulatory techniques, from theoretical and basic neuromodulation models to clinical findings. We welcome original research papers, theoretical and methodology papers, and review papers describing the generation, use, and knowledge translation of neuromodulation, especially those exploring new technologies, precision medicine, transdiagnosis approach, and biomarkers.
Dr. Felipe Fregni
Dr. Kevin Pacheco-Barrios
Dr. Aurore Thibaut
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuromodulation
- non-pharmacological interventions
- neuropsychiatric conditions
- chronic pain
- brain injury
- computational models
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issues
- Neuromodulation from Theory to Therapy Volume II in Biomedicines (3 articles)
- Feature Papers in Neuromodulation and Brain Stimulation in Biomedicines (2 articles)